Jennifer Brown, MD, discusses the choice in chemoimmunotherapy, FCR (fludarabine, cyclophosphamide and rituximab) vs BR. FCR has been the standard therapy for previously untreated fit patients with CLL under about the age of 70. While BR (benda

Basics of Small Cell Lung Cancer

Aug 23rd, 2016 4m 55s

Lung Cancer Video Library ASCO 2016 Rachel Sanborn Basics of Small Cell Lung Cancer

Adjuvant Chemotherapy for Elderly and Frail Patients

Aug 23rd, 2016 6m 30s

Lung Cancer Video Library ASCO 2016 - Rachel Sanborn - Adjuvant Chemotherapy for Elderly and Frail Patients

Rachel Sanborn - Adjuvant Chemotherapy for Early Stage NSCLC Patients, part 1

Aug 22nd, 2016 5m 28s

Lung Cancer Video Library - Rachel Sanborn - Adjuvant Chemotherapy for Early Stage NSCLC Patients, part 1

New Trials of Targeting Therapies to Treat Leptomeningeal Carcinomatosis

Aug 11th, 2016 4m 31s

GRACE is happy to present the 8th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer. Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable discuss

ASCO 2016 LC RT Vid 8 - Promising Early Results for Treatments

Aug 11th, 2016 4m 59s

Immuno-oncology Developments - Combinations and Use as First-Line Therapy

Aug 11th, 2016 7m 11s

GRACE is happy to present the 6th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer. Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable discuss

Does Current Evidence Support Favoring Proton-Beam Radiation

Aug 4th, 2016 8m 36s

GRACE is happy to present the 6th video in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer. Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable d

J-Alex Trial: Should Alecensa Replace Xalkori as First-Line ALK Therapy?

Aug 4th, 2016 11m 2s

GRACE is happy to present the 5th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer. Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable discuss

Are There Less Toxic Alternatives to the Extreme Regimen

Aug 3rd, 2016 4m 6s

GRACE is happy to present the 9th video in our series ASCO 2016 Head and Neck Roundtable, Treating Head and Neck Cancer. Featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD, this roundtable discussion, moderated by Dr. Weiss, h

Promising Early Data for Oral Inhibitor Buparlisib

Aug 3rd, 2016 1m 55s

GRACE is happy to present the 8th video in our series ASCO 2016 Head and Neck Roundtable, Treating Head and Neck Cancer. Featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD, this roundtable discussion, moderated by Dr. Weiss, h

Using Immunotherapy as First-Line Treatment and in Combinations

Aug 2nd, 2016 4m 36s

7th video in our series ASCO 2016 Head and Neck Roundtable, featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD. Dr. Weiss moderates the discussion regarding ASCO 2016 HN RT-Using Immunotherapy as First-Line Treatment and in Com

Keynote 55 Pembrolizumab for Heavily Pre-Treated Patients

Jul 31st, 2016 4m 17s

6th video in our series ASCO 2016 Head and Neck Roundtable, featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD. Dr. Weiss moderates the discussion regarding keynote 55: Pembrolizumab for heavily pre-treated patients.

Using Biomarkers in Immunotherapy

Jul 28th, 2016 2m 4s

GRACE is happy to present the 3rd video in our series ASCO 2016 Head and Neck Roundtable, Treating Head and Neck Cancer. Featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD, this roundtable discussion, moderated by Dr. Weiss,

Common Side Effects of PD-1 Inhibitors

Jul 20th, 2016 4m 16s

GRACE is happy to present the 4th video in our series ASCO 2016 Head and Neck Roundtable, Treating Head and Neck Cancer. Featuring Jared Weiss, MD, Joshua Baumi, MD, and Tanguy Seiwert, MD, this roundtable discussion, moderated by Dr. Weiss, h

Data from Keynote 12 Nivolumab and Pembrolizumab

Jul 19th, 2016 4m 11s

GRACE is happy to present the 3rd video in our series ASCO 2016 Head and Neck Roundtable, Treating Head and Neck Cancer. Featuring Jared Weiss, MD, Joshua Baumi, MD, and Tanguy Seiwert, MD, this roundtable discussion, moderated by Dr. Weiss, h

How Promising Are The Results From Checkmate 141?

Jul 19th, 2016 2m 58s

GRACE is happy to present the 2nd video in our series, ASCO 2016 Head and Neck Roundtable, Treating Head and Neck Cancer. Featuring Jared Weiss, MD, Joshua Baumi, MD, and Tanguy Seiwert, MD, this roundtable discussion, moderated by Dr. Weiss,

Local Consolidation Therapies for Oligomatastases

Jul 18th, 2016 12m 31s

GRACE is happy to present the 4th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer. Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable discuss

The Immune System and PD-1 Inhibitors

Jul 15th, 2016 1m 45s

GRACE is happy to present the 1st video in our series ASCO 2016 Head and Neck Roundtable, Treating Head and Neck Cancer. Featuring Jared Weiss, MD, Joshua Baumi, MD, and Tanguy Seiwert, MD, this roundtable discussion, moderated by Dr. Weiss, h

Urine or Blood Testing Instead of Lung Biopsy Shows Promise for Finding EGFR Mutations

Jul 13th, 2016 8m 29s

GRACE is happy to present our ASCO 2016 Lung Cancer Roundtable series, Highlights and New Approaches in Lung Cancer. Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable discussion, modera

Can Online Patient Groups Speed New Targeted Therapies?

Jul 8th, 2016 4m 47s

Rova-T Shows Promise in Small Cell Lung Cancer

Jul 6th, 2016 4m 58s

1st Video in the GRACE ASCO 2016 Lung Cancer Roundtable series, featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD. Dr. West moderates this roundtable discussion highlighting studies presented at ASCO 20

Significance Of IGHV Mutations & How They Are Assessed

Jun 21st, 2016 2m 49s

CLL, Chronic Lymphocytic Leukemia, What is the significance of IGHV mutations and how they are assessed. Presented by Jennifer Brown, M.D., Ph.D., Director of the CLL Center and the Dana-Farber Cancer Institute.

Immunotherapy Combinations

Apr 27th, 2016 4m 35s

Dr. Jack West, Swedish Cancer Institute, discusses current trialsseeking to determine the efficacy of combining immunotherapy agentsin lung cancer.

Immunotherapy as First-Line Treatment

Apr 26th, 2016 3m 46s

Dr. Jack West, Swedish Cancer Institute, raises the question ofwhether to use immune checkpoint inhibitors as first-line treatmentof lung cancer, alone or in combination withchemotherapy.